Smoothing the Path
Medication adherence continues to be a challenge for the health care community. Successful treatment of disease simply cannot occur if patients are not adherent to medications. In addition,...
View ArticleTexting For Meds
Could better medication adherence be just a “text away”? According to a new analysis taking a closer look at several previous studies about adherence, when patients receive text reminders about their...
View ArticleStudy Finds Low Levels of Adherence & Persistence Remain Barriers to Reducing...
PARSIPPANY, N.J.–(BUSINESS WIRE)–Despite improved diagnosis and advances in treatment options for individuals with Type 2 Diabetes, sub-optimal therapy adherence and persistence result in significant...
View ArticleSticking Points
There are several ‘sticking points’ that get in the way of patients sticking with their prescribed treatment. In fact, medication nonadherence remains a key area of wasted health care resources. A...
View ArticleWalgreens Partners with HealthPrize Technologies for Game-Based Drug...
NORWALK, Conn., Aug. 16, 2016 /PRNewswire/ — HealthPrize Technologies today announced a collaboration with Walgreens through which the HealthPrize Action Engine® patient engagement and medication...
View ArticleCVS Study Shows Value in Tailoring Medication Adherence Interventions to...
WOONSOCKET, R.I., Aug. 22, 2016 /PRNewswire/ — A new study from the CVS Health Research Institute found that interventions to keep patients with common chronic conditions adherent is extraordinarily...
View ArticleBreaking Down Restrictions
For many years, the standard plan for treating hepatitis C infections called for excluding active drug users. Experts at the 5th International Symposium on Hepatitis Care in Substance Users who...
View ArticleMedication Nonadherence Causes Pharmaceutical Companies to Lose $637 Billion...
NORWALK, Conn., Nov. 16, 2016 /PRNewswire/ — HealthPrize Technologies today announced the publication of an update to a research paper co-authored with Capgemini estimating annual pharmaceutical...
View ArticlePrime Therapeutics Finds Poor Adherence to High-Cost Multiple Sclerosis Therapy
PAUL, Minn., April 23, 2018 /PRNewswire/ — Two new studies by pharmacy benefit manager Prime Therapeutics LLC (Prime), using real-world integrated medical and pharmacy data, show members with multiple...
View ArticleAvella’s Use of AdhereTech Improves Adherence of Multiple Specialty...
PHOENIX, July 10, 2018 /PRNewswire/ — Avella Specialty Pharmacy and AdhereTech are proud to share the results that their successful partnership continues to have for patients. Avella currently uses...
View Article